KKR (KKR) announced that it has acquired a majority ownership stake in HealthCare Royalty Partners. This strategic partnership will enable KKR to enhance its capabilities in biopharma royalty and credit investing, while expanding the firm’s existing footprint in the life sciences ecosystem. Since inception, the firm has committed over $7B in capital and manages approximately $3B in assets with a portfolio that spans over 10 therapeutic areas and over 55 products.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KKR:
- Capital Group proposes offering of a new public-private equity interval fund
- Harley-Davidson confirms strategic partnership with KKR and PIMCO
- Harley-Davidson: HDFS to sell 4.9% interest to vehicles managed by KKR and PIMCO
- Harley-Davidson in financing unit deal talks with Pimco, KKR, Bloomberg reports
- KKR Upcoming Earnings Report: What to Expect?